Hodgkin lymphoma incidence on the decline worldwideMay 29, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHodgkin LymphomaNon-Hodgkin Lymphoma
CAR T-cell therapy appears feasible in HLMay 28, 2015Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Symptoms confer higher-than-expected risk of HL, NHLMay 1, 2015Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin Lymphoma
Susceptibility to 2nd cancers in WM/LPL survivorsApril 30, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLHodgkin LymphomaNon-Hodgkin Lymphoma
HL survivors have long-term risk of cardiovascular diseaseApril 28, 2015Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
PET scans could prevent unnecessary RT in HLApril 23, 2015Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Drug produces ‘dramatic’ results in HLMarch 19, 2015Lymphoma & Plasma Cell DisordersTransplantationHodgkin Lymphoma
New radiation guidelines for pediatric HLMarch 5, 2015Lymphoma & Plasma Cell DisordersPediatricsHodgkin Lymphoma
Cancer care spending doesn’t correlate to lives savedMarch 4, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated IssuesHodgkin LymphomaNon-Hodgkin Lymphoma
Why EBV-positive lymphomas resist IFN therapyJanuary 28, 2015Lymphoma & Plasma Cell DisordersRelated IssuesHodgkin LymphomaNon-Hodgkin Lymphoma
HIV doesn’t hinder lymphoma patients’ response to ASCTJanuary 7, 2015Lymphoma & Plasma Cell DisordersTransplantationHodgkin LymphomaNon-Hodgkin Lymphoma
Older patients benefit from brentuximab treatmentJanuary 6, 2015Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Classic HL vulnerable to PD-1 blockade therapyDecember 24, 2014Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Brentuximab combinations highly active in Hodgkin lymphomaDecember 19, 2014Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
PFS improvement will translate to OS, speaker saysDecember 9, 2014Lymphoma & Plasma Cell DisordersTransplantationHodgkin Lymphoma
